Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Cygenica Limited currently maintains 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This workload is distributed to a distinct examiner and a distinct art unit. The portfolio shows a streamlined prosecution profile with only one active matter under review. This allows the company to focus its resources on overcoming the specific rejections or objections raised in this case.
VARADARAJ, ARCHANA is the busiest examiner for the company, managing 1 pending office action. This action represents the entirety of the company's pending prosecution. The company's immediate patent strategy in this technology area is focused on the interaction with this specific examiner. Understanding the examiner's approach to biotechnology will be crucial for a successful outcome. Since there is a distinct examiner and a distinct art unit, the company avoids the complexity of managing multiple examiner personalities or differing interpretations of patent law within the same portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VARADARAJ, ARCHANA | 1 | 80.0% | +33.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18165613 | CELL MEMBRANE PENETRATING CONJUGATES | VARADARAJ, ARCHANA | 56d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18165613 | CELL MEMBRANE PENETRATING CONJUGATES | VARADARAJ, ARCHANA | 56d overdue |
| Art Unit | Apps |
|---|---|
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18165613 | CELL MEMBRANE PENETRATING CONJUGATES | VARADARAJ, ARCHANA | 1658 | §101§102§103Other | Non-Final OA | 56d overdue | Pending | Feb 07, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial